Clinical Trials
4 trialsNCT06242691 2026-06-05
MK-1200-002
Merck Sharp & Dohme LLC
Phase 1/2 Completed
NCT05571969 2026-06-01
Study of PARPi 2X-121 as Monotherapy and in Combination With Dovitinib in Patients With Advanced Solid Tumors
Allarity Therapeutics
Phase 1 Terminated
NCT05063318 2025-09-02
Clinical Trial of Lurbinectedin (PM01183) in Patients With Advanced Solid Tumors
PharmaMar
Phase 1 Completed
NCT03853109 2025-07-20
AMG 404 in Patients With Advanced Solid Tumors
Amgen
Phase 1 Completed